Intersect Ent Inc
NASDAQ:XENT
Intersect Ent Inc
NASDAQ:XENT
Price:
28.24 USD
Market Closed
Updated:
Jun 1, 2024
Intersect Ent Inc
Additional Paid In Capital
|
Intersect Ent Inc
Additional Paid In Capital Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Intersect Ent Inc
NASDAQ:XENT
|
Additional Paid In Capital
$397.5m
|
CAGR 3-Years
8%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Additional Paid In Capital
$19.8B
|
CAGR 3-Years
1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
25%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Additional Paid In Capital
$20.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
2%
|
|
|
Stryker Corp
NYSE:SYK
|
Additional Paid In Capital
$2.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Additional Paid In Capital
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Additional Paid In Capital
$8.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
See Also
What is Intersect Ent Inc's Additional Paid In Capital?
Additional Paid In Capital
397.5m
USD
397.5m
USD
Based on the financial report for Mar 31, 2022, Intersect Ent Inc's Additional Paid In Capital amounts to 397.5m USD.
What is Intersect Ent Inc's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
8%
8%
Over the last year, the Additional Paid In Capital growth was 6%. The average annual Additional Paid In Capital growth rates for Intersect Ent Inc have been 8% over the past three years , 8% over the past five years .
You don't have any saved screeners yet
